Can Wegovy Cause a High Heart Rate?

What actually happens to your heart rate on Wegovy?

The honest answer is: a little, for most people. In the STEP 1 trial published in the New England Journal of Medicine, adults taking semaglutide 2.4mg saw their resting heart rate rise by an average of around 1–4 beats per minute compared with placebo. That is a statistically real finding, but it sits well within the range your heart rate varies naturally across a normal day.

Palpitations (the sensation of a racing, fluttering or pounding heart) are classed as an uncommon side effect (affecting between 1 in 100 and 1 in 10 people) in the Wegovy Patient Information Leaflet. So does Wegovy cause a fast heart rate in a clinically meaningful way for the majority of users? No. But for a subset of people, particularly in the early weeks of treatment or after a dose increase, the feeling can be unsettling enough to raise the question. That is a completely reasonable thing to want clarity on.

One practical note: the palpitations that some people notice tend to cluster around the same window as other early side effects, the first day or two after an injection. If you are tracking your pulse and notice a jump, logging the timing relative to your injection day gives your prescriber genuinely useful information.

When a raised heart rate on semaglutide warrants attention

The difference between a mildly elevated resting rate and something that needs prompt review matters. A persistently high heart rate on Wegovy (one that does not settle between injection days, is accompanied by chest pain, breathlessness or dizziness, or is significantly above your personal baseline) is a reason to contact your prescriber or, if severe, seek urgent medical help.

The NHS medicines guidance for semaglutide advises telling your doctor or pharmacist if you experience a fast or irregular heartbeat, and notes that serious allergic reactions, though rare, can also cause a racing heart alongside swelling or difficulty breathing. Treat those two scenarios differently: a mild background elevation is something to monitor and mention at your next review; symptoms alongside chest tightness or facial swelling need same-day assessment.

People with a diagnosed arrhythmia, those already managing resting tachycardia, or anyone taking medicines that also affect heart rate should flag this during the consultation. For a fuller picture of how Wegovy affects heart rate across different situations and patient profiles, it is worth reading through the detail before your consultation. It is not a disqualifying factor in itself, it shapes what a prescriber looks for and how closely they want to monitor you.

How prescribers weigh this against the benefits

A small rise in resting heart rate does not exist in isolation. Sustained weight reduction of the kind seen with semaglutide (averaging around 15% of body weight in STEP 1 over 68 weeks) is associated with meaningful reductions in blood pressure, improved lipid profiles, and, in eligible adults, a reduced risk of major cardiovascular events. The MHRA and NICE assessed this risk-benefit profile before recommending semaglutide for weight management under NICE technology appraisal TA875.

For most people, the clinical calculation favours treatment. The modest average heart-rate rise does not outweigh the cardiovascular gains from significant weight loss. That said, the calculation is individual. A prescriber who knows your baseline heart rate, your medication list and your cardiac history will reach a more accurate conclusion than any general article can. It is also worth knowing that Wegovy can affect liver enzymes in some people, so a full picture of your bloodwork is useful context for your prescriber alongside any heart-rate concerns.

If you are exploring your options, checking your eligibility through a free consultation is the practical next step. If cost is part of the picture, our weight-loss treatment overview explains what private treatment involves and what is included in the price.

Questions to bring to your prescriber about heart rate and Wegovy

Going into a consultation knowing what to ask saves time and gets you better answers. A few things worth raising if heart rate is your specific concern: What is my resting heart rate right now, and would you consider it a baseline risk factor? Are any of my current medicines likely to interact with semaglutide in a way that affects heart rate? At what point, and with what symptoms, should I call for advice rather than wait for my next scheduled review? If you are unsure whether your symptoms cross that threshold, our page on whether Wegovy can cause a rapid heart rate covers the distinction in more detail.

At nume, a real prescriber reads your full health questionnaire the same day you submit it. Not a scoring algorithm, not an automated pathway, a named GPhC-registered Independent Prescriber who can factor in your cardiac history and flag anything worth monitoring. Our clinical team takes this kind of individual context seriously.

Once treatment is approved and dispensed, your pen arrives via DPD the next working day in plain, unbranded packaging, no indication of what is inside. Aftercare is available seven days a week, so if a question comes up between doses, there is someone to ask. You can also read through our FAQs for answers to other common queries about starting treatment.